Desferrioxamine-Mesilate shortage status
No active shortage currently reported by the regulators Mederti tracks.
Last updated 13 May 2026 · sourced from official medicines regulators
- Generic name (INN)
- Desferrioxamine-Mesilate
- Brand names
- Dbl Desferrioxamine Mesylate For Injection Bp
- ATC code
- V03AC01
- Class
- Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Recent shortage history
- Australia: resolved 10 Feb 2026 (began 5 Jan 2026)
Frequently asked questions
Is Desferrioxamine-Mesilate currently in shortage?
No active shortage of Desferrioxamine-Mesilate is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Desferrioxamine-Mesilate shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Cobicistat · Dexrazoxane · Dexrazoxane (Chlorhydrate De) · Deferiprone · Andexanet Alfa · Andexanet-Alfa
Get alerted when Desferrioxamine-Mesilate status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.